Israel’s CollPlant has been awarded the EU CE Mark for VergenixSTR, a soft tissue repair matrix for the treatment of tendinopathy (tendon injury or disease and associated pain); Hebrew University scientists’ peptide treatment for HIV that uses multiple copies of the virus to make it self-destruct has now been tested on the blood from AIDS patients, and much more.
By: Michael Ordman
ISRAEL’S MEDICAL ACHIEVEMENTS
European approval for tendon pain treatment
Israel’s CollPlant has been awarded the EU CE Mark for VergenixSTR, a soft tissue repair matrix for the treatment of tendinopathy (tendon injury or disease and associated pain). VergenixSTR is based on CollPlant’s proprietary plant-based collagen technology.
Causing HIV virus to self-destruct
Hebrew University scientists’ peptide treatment for HIV that uses multiple copies of the virus to make it self-destruct has now been tested on the blood from AIDS patients and has similar results to earlier clinical trials.
New treatment for cognitive impairment
Israel’s Therapix Biosciences has developed a unique tablet for sublingual (under the tongue) administration of THC. A clinical trial of this tablet is anticipated to commence early 2017 for treatment of impairments in cognitive functioning, including early stages of Alzheimer’s disease.
Israeli-Arab village has highest percentage of doctors
Israel has 3.4 doctors per 1000 residents (OECD average is 3.3 per 1000). But for the 24,000 residents of the Israeli-Arab village of Arraba in the Galilee, there are 6 doctors per 1000 residents. Dr. Hatim Kanaaneh is credited with boosting numbers of local Arab doctors.
Medical incubator opens its doors
Israel’s Chief Scientist has licensed medical incubator MEDX, which has been formally launched and plans to submit 3-4 projects to the Israel Innovation Authority in the coming months. It will focus on non-invasive medical devices.
Israel’s first exclusive digital health fund
Israel’s leading global equity crowdfunding platform OurCrowd has launched Qure – Israel’s first exclusively focused digital health fund. The fund will invest in innovative digital health startups. OurCrowd will work with Johns Hopkins University to bring novel ideas to market.
Video of Brainstorm’s ALS treatment
New ABC TV video of the 4-year human trials of the stem cell treatment from Israel’s Brainstorm on 26 ALS patients at Jerusalem’s Hadassah Medical Center. 90% have shown positive change. The patients’ own bone marrow stem cells are extracted, treated and re-inserted.
El Al flight delayed – to save a life
15 mins before departure, El Al flight attendant Nitzan Rabinowitz went to look for her cell phone. At the train station, an Asian man had collapsed and Nitzan administered CPR until paramedics arrived. Nitzan never told passengers why their flight was delayed, but her phone was later found.
IDF to train UN peacekeeping forces in field medicine
United Nations peacekeeping forces are to participate in a special emergency field medicine seminar headed by the Israeli military and local medical professionals. They will learn the unique methods Israel uses to deal with cases involving emergency medicine on the ground.
Click here for all of this week’s Good News from Israel.